2007
DOI: 10.1002/cbic.200600375
|View full text |Cite
|
Sign up to set email alerts
|

A Genomic Screening Approach to the Structure‐Guided Identification of Drug Candidates from Natural Sources

Abstract: The potential of actinomycetes to produce natural products has been exploited for decades. Recent genomic sequence analyses have revealed a previously unrecognized biosynthetic potential and diversity. In order to rationally exploit this potential, we have developed a sequence-guided genetic screening strategy. In this "genome mining" approach, genes that encode tailoring enzymes from natural product biosyntheses pathways serve as indicator genes for the identification of strains that have the genetic potentia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
73
0
2

Year Published

2008
2008
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(76 citation statements)
references
References 44 publications
1
73
0
2
Order By: Relevance
“…Primers K1F (5¢-GTSCCSGTSCCRTGSSCYTCSAC-3¢) and M6R (5¢-GCSATGGAYCCSCARCARCGSVT-3¢) (Schirmer et al, 2005), KSaF (5¢-TSGCSTGCTTGGAYGCSATC-3¢) and KSaR (5¢-TSGCSTGC-TTGGAYGCSATC-3¢) (Mets€ a-Ketel€ a et al, 1999), A3F (5¢-GCSTACSY-SATSTACACSTCSGG-3¢) and A7R (5¢-SASGTCVCCSGTSCGCTAS-3¢) (Ayuso-Sacido & Genilloud, 2005), and B4F (5¢-TTCCCSCGSTAC-CASATCGGSGAG-3¢) and B7R (5¢-GSGGGATSWMCCAGWAC-CASCC-3¢) (Hornung et al, 2007) were employed to amplify polyketide synthase gene type I PKS, the KSa gene in the type II PKS polyketide synthase gene cluster, the non-ribosomal peptide synthetase gene (NRPS) and the FADH 2 -dependent halogenase gene, respectively. PCR amplification was carried out in 20 µl PCR reaction mixture consisting of 1Âbuffer with 1.5 mM Mg 2+ , 0.5 mM dNTP mixture, 1 µM of primers, 1 µl of template DNA, 1 U Taq polymerase and 1.25 µg µl À1 BSA.…”
Section: Methodsmentioning
confidence: 99%
“…Primers K1F (5¢-GTSCCSGTSCCRTGSSCYTCSAC-3¢) and M6R (5¢-GCSATGGAYCCSCARCARCGSVT-3¢) (Schirmer et al, 2005), KSaF (5¢-TSGCSTGCTTGGAYGCSATC-3¢) and KSaR (5¢-TSGCSTGC-TTGGAYGCSATC-3¢) (Mets€ a-Ketel€ a et al, 1999), A3F (5¢-GCSTACSY-SATSTACACSTCSGG-3¢) and A7R (5¢-SASGTCVCCSGTSCGCTAS-3¢) (Ayuso-Sacido & Genilloud, 2005), and B4F (5¢-TTCCCSCGSTAC-CASATCGGSGAG-3¢) and B7R (5¢-GSGGGATSWMCCAGWAC-CASCC-3¢) (Hornung et al, 2007) were employed to amplify polyketide synthase gene type I PKS, the KSa gene in the type II PKS polyketide synthase gene cluster, the non-ribosomal peptide synthetase gene (NRPS) and the FADH 2 -dependent halogenase gene, respectively. PCR amplification was carried out in 20 µl PCR reaction mixture consisting of 1Âbuffer with 1.5 mM Mg 2+ , 0.5 mM dNTP mixture, 1 µM of primers, 1 µl of template DNA, 1 U Taq polymerase and 1.25 µg µl À1 BSA.…”
Section: Methodsmentioning
confidence: 99%
“…This cluster also contained a halogenase gene next to the PKS/NRPS hybrid gene (data not shown). The products of this pathway may therefore be halogen-containing polyketide-peptide hybrid compounds (Gao and Huang, 2009;Hornung et al, 2007).…”
Section: Pks/nrps Hybrid Gene Clustersmentioning
confidence: 99%
“…5), which can be purified and structurally characterized as in the first approach. CBS40 is an example of a novel metabolite that has been identified by this approach (Hornung et al, 2007). One potential obstacle which often has to be overcome in the Fig.…”
Section: Strategies For Identifying the Metabolic Products Of Crypticmentioning
confidence: 99%